95 related articles for article (PubMed ID: 22581839)
21. Coexpression of NOR1 and SIX3 proteins in extraskeletal myxoid chondrosarcomas without detectable NR4A3 fusion genes.
Hisaoka M; Okamoto S; Yokoyama K; Hashimoto H
Cancer Genet Cytogenet; 2004 Jul; 152(2):101-7. PubMed ID: 15262426
[TBL] [Abstract][Full Text] [Related]
22. The AF2 domain of the orphan nuclear receptor TEC is essential for the transcriptional activity of the oncogenic fusion protein EWS/TEC.
Maltais A; Filion C; Labelle Y
Cancer Lett; 2002 Sep; 183(1):87-94. PubMed ID: 12049818
[TBL] [Abstract][Full Text] [Related]
23. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain.
Prasad DD; Ouchida M; Lee L; Rao VN; Reddy ES
Oncogene; 1994 Dec; 9(12):3717-29. PubMed ID: 7970732
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation.
Labelle Y; Zucman J; Stenman G; Kindblom LG; Knight J; Turc-Carel C; Dockhorn-Dworniczak B; Mandahl N; Desmaze C; Peter M
Hum Mol Genet; 1995 Dec; 4(12):2219-26. PubMed ID: 8634690
[TBL] [Abstract][Full Text] [Related]
25. Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.
Sjögren H; Meis-Kindblom JM; Orndal C; Bergh P; Ptaszynski K; Aman P; Kindblom LG; Stenman G
Am J Pathol; 2003 Mar; 162(3):781-92. PubMed ID: 12598313
[TBL] [Abstract][Full Text] [Related]
26. Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion.
Broehm CJ; Wu J; Gullapalli RR; Bocklage T
Cancer Genet; 2014 Jun; 207(6):276-80. PubMed ID: 25130955
[TBL] [Abstract][Full Text] [Related]
27. Spectrum of cytomorphological features, including literature review, of an extraskeletal myxoid chondrosarcoma with t(9;22)(q22;q12) (TEC/EWS) results in one case.
Kumar R; Rekhi B; Shirazi N; Pais A; Amare P; Gawde D; Jambhekar N
Diagn Cytopathol; 2008 Dec; 36(12):868-75. PubMed ID: 18925568
[TBL] [Abstract][Full Text] [Related]
28. Characterization and chromosomal mapping of the human TFG gene involved in thyroid carcinoma.
Mencinger M; Panagopoulos I; Andreasson P; Lassen C; Mitelman F; Aman P
Genomics; 1997 May; 41(3):327-31. PubMed ID: 9169129
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization analysis of extraskeletal myxoid chondrosarcomas using EWSR1 and NR4A3 probes.
Noguchi H; Mitsuhashi T; Seki K; Tochigi N; Tsuji M; Shimoda T; Hasegawa T
Hum Pathol; 2010 Mar; 41(3):336-42. PubMed ID: 19775727
[TBL] [Abstract][Full Text] [Related]
30. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
Lessnick SL; Braun BS; Denny CT; May WA
Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
[TBL] [Abstract][Full Text] [Related]
31. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
Laflamme C; Filion C; Bridge JA; Ladanyi M; Goldring MB; Labelle Y
Cancer Res; 2003 Jan; 63(2):449-54. PubMed ID: 12543801
[TBL] [Abstract][Full Text] [Related]
32. Skeletal and extraskeletal myxoid chondrosarcoma: related or distinct tumors?
Rubin BP; Fletcher JA
Adv Anat Pathol; 1999 Jul; 6(4):204-12. PubMed ID: 10410173
[TBL] [Abstract][Full Text] [Related]
33. Identification of PU.1 and Sp1 as essential transcriptional factors for the promoter activity of mouse tec gene.
Honda H; Ozawa K; Yazaki Y; Hirai H
Biochem Biophys Res Commun; 1997 May; 234(2):376-81. PubMed ID: 9177279
[TBL] [Abstract][Full Text] [Related]
34. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
Roccato E; Pagliardini S; Cleris L; Canevari S; Formelli F; Pierotti MA; Greco A
Oncogene; 2003 Feb; 22(6):807-18. PubMed ID: 12584559
[TBL] [Abstract][Full Text] [Related]
35. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
36. The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25.
Ladanyi M; Lui MY; Antonescu CR; Krause-Boehm A; Meindl A; Argani P; Healey JH; Ueda T; Yoshikawa H; Meloni-Ehrig A; Sorensen PH; Mertens F; Mandahl N; van den Berghe H; Sciot R; Dal Cin P; Bridge J
Oncogene; 2001 Jan; 20(1):48-57. PubMed ID: 11244503
[TBL] [Abstract][Full Text] [Related]
37. Extraskeletal myxoid chondrosarcoma: multimodal diagnosis and identification of a new cytogenetic subgroup characterized by t(9;17)(q22;q11).
Bjerkehagen B; Dietrich C; Reed W; Micci F; Saeter G; Berner A; Nesland JM; Heim S
Virchows Arch; 1999 Nov; 435(5):524-30. PubMed ID: 10592057
[TBL] [Abstract][Full Text] [Related]
38. Identification of anaplastic lymphoma kinase variant translocations using 5'RACE.
Hernández L; Campo E
Methods Mol Med; 2005; 115():295-314. PubMed ID: 15998975
[TBL] [Abstract][Full Text] [Related]
39. Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma.
Clark J; Benjamin H; Gill S; Sidhar S; Goodwin G; Crew J; Gusterson BA; Shipley J; Cooper CS
Oncogene; 1996 Jan; 12(2):229-35. PubMed ID: 8570200
[TBL] [Abstract][Full Text] [Related]
40. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
Bertolotti A; Bell B; Tora L
Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
